Skip to content
777 Sourcing.

Capability

commercialization of drug treatments

Suppliers
1
States & provinces
1
Countries
1

1 commercialization of drug treatments supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

CERVOMED, INC.

BOSTON, MA

CervoMed is a clinical stage biotechnology company focused on developing treatments for age-related neurologic disorders. Its lead product candidate, neflamapimod, is an investigational, orally administered, small molecule brain penetrant that inhibits the protein kinase p38 alpha, and is in clinical development for neurodegenerative diseases such as dementia with Lewy bodies, frontotemporal dementia and recovery after stroke. Until August 2023, CervoMed was known as EIP Pharma Inc., now a wholly-owned subsidiary.

clinical developmentdrug development

Compiled from public sources

Related capabilities

Other processes offered by the shops that list commercialization of drug treatments.

Browse all capabilities